BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 29495973)

  • 1. MicroRNA-623 Targets Cyclin D1 to Inhibit Cell Proliferation and Enhance the Chemosensitivity of Cells to 5-Fluorouracil in Gastric Cancer.
    Jiang L; Yang W; Bian W; Yang H; Wu X; Li Y; Feng W; Liu X
    Oncol Res; 2018 Dec; 27(1):19-27. PubMed ID: 29495973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitization of Gastric Cancer Cells to 5-FU by MicroRNA-204 Through Targeting the TGFBR2-Mediated Epithelial to Mesenchymal Transition.
    Li LQ; Pan D; Chen Q; Zhang SW; Xie DY; Zheng XL; Chen H
    Cell Physiol Biochem; 2018; 47(4):1533-1545. PubMed ID: 29940566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-193b inhibits the proliferation, migration and invasion of gastric cancer cells via targeting cyclin D1.
    Wang L; Zhang Y; Zhao L; Liu S; Yu S; Ma Y; Sun G
    Acta Histochem; 2016 May; 118(4):323-30. PubMed ID: 27071318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of MicroRNA-147 Inhibits Cell Proliferation and Increases the Chemosensitivity of Gastric Cancer Cells to 5-Fluorouracil by Directly Targeting PTEN.
    Shen J; Niu W; Zhang H; Jun M; Zhang H
    Oncol Res; 2018 Jul; 26(6):901-911. PubMed ID: 28950928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-17 inhibition overcomes chemoresistance and suppresses epithelial-mesenchymal transition through a DEDD-dependent mechanism in gastric cancer.
    Wu DM; Hong XW; Wang LL; Cui XF; Lu J; Chen GQ; Zheng YL
    Int J Biochem Cell Biol; 2018 Sep; 102():59-70. PubMed ID: 29953965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lentivirus-mediated shRNA targeting of cyclin D1 enhances the chemosensitivity of human gastric cancer to 5-fluorouracil.
    Seo JH; Jeong ES; Lee KS; Heo SH; Jeong DG; Choi YK
    Int J Oncol; 2013 Dec; 43(6):2007-14. PubMed ID: 24100731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-449a Regulates proliferation and chemosensitivity to cisplatin by targeting cyclin D1 and BCL2 in SGC7901 cells.
    Hu J; Fang Y; Cao Y; Qin R; Chen Q
    Dig Dis Sci; 2014 Feb; 59(2):336-45. PubMed ID: 24248414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-155 expression inversely correlates with pathologic stage of gastric cancer and it inhibits gastric cancer cell growth by targeting cyclin D1.
    Ma Z; Ma Y; Xia Q; Li Y; Li R; Chang W; Chen J; Leng Z; Tao K
    J Cancer Res Clin Oncol; 2016 Jun; 142(6):1201-12. PubMed ID: 26955820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of miR-34c after silencing E2F transcription factor 1 inhibits paclitaxel combined with cisplatin resistance in gastric cancer cells.
    Zheng H; Wang JJ; Yang XR; Yu YL
    World J Gastroenterol; 2020 Feb; 26(5):499-513. PubMed ID: 32089626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-16-1 Targeted Silences Far Upstream Element Binding Protein 1 to Advance the Chemosensitivity to Adriamycin in Gastric Cancer.
    Zhao D; Zhang Y; Song L
    Pathol Oncol Res; 2018 Jul; 24(3):483-488. PubMed ID: 28667493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-375-3p enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer.
    Xu F; Ye ML; Zhang YP; Li WJ; Li MT; Wang HZ; Qiu X; Xu Y; Yin JW; Hu Q; Wei WH; Chang Y; Liu L; Zhao Q
    Cancer Sci; 2020 May; 111(5):1528-1541. PubMed ID: 32073706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor expression of microRNA-135b results in the inhibition of cisplatin resistance and proliferation and induces the apoptosis of gastric cancer cells through MST1-mediated MAPK signaling pathway.
    Zhou J; Chen Q
    FASEB J; 2019 Mar; 33(3):3420-3436. PubMed ID: 30576232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rosmarinic acid reduces the resistance of gastric carcinoma cells to 5-fluorouracil by downregulating FOXO4-targeting miR-6785-5p.
    Yu C; Chen DQ; Liu HX; Li WB; Lu JW; Feng JF
    Biomed Pharmacother; 2019 Jan; 109():2327-2334. PubMed ID: 30551491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin D1 antisense oligodexoyneucleotides inhibits growth and enhances chemosensitivity in gastric carcinoma cells.
    Shuai XM; Han GX; Wang GB; Chen JH
    World J Gastroenterol; 2006 Mar; 12(11):1766-9. PubMed ID: 16586549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoblastoma tumor suppressor gene 1 enhances 5-Fluorouracil chemosensitivity through SDF-1/CXCR4 axis by regulating autophagy in gastric cancer.
    Tang H; Long Q; Zhuang K; Han K; Zhang X; Guo H; Lu X
    Pathol Res Pract; 2021 Aug; 224():153532. PubMed ID: 34214844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of microRNA-34a enhances the DDP sensitivity of gastric cancer cells by modulating proliferation and apoptosis via targeting MET.
    Zhang Z; Kong Y; Yang W; Ma F; Zhang Y; Ji S; Ma EM; Liu H; Chen Y; Hua Y
    Oncol Rep; 2016 Oct; 36(4):2391-7. PubMed ID: 27513895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of microRNA-193-3p inhibits tumor proliferation migration and chemoresistance in human gastric cancer by regulating PTEN gene.
    Jian B; Li Z; Xiao D; He G; Bai L; Yang Q
    Tumour Biol; 2016 Jul; 37(7):8941-9. PubMed ID: 26753960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-519d reduces the 5-fluorouracil resistance in colorectal cancer cells by down-regulating the expression of CCND1.
    Huang R; Lin JY; Chi YJ
    Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2869-2875. PubMed ID: 29771440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway.
    Liu B; Liu Y; Zhao L; Pan Y; Shan Y; Li Y; Jia L
    Mol Carcinog; 2017 Dec; 56(12):2669-2680. PubMed ID: 28767179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-143 inhibits cell proliferation and invasion by targeting DNMT3A in gastric cancer.
    Zhang Q; Feng Y; Liu P; Yang J
    Tumour Biol; 2017 Jul; 39(7):1010428317711312. PubMed ID: 28718369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.